Author:
Daniel Michael G.,Pawlik Timothy M.,Fader Amanda N.,Esnaola Nestor F.,Makary Martin A.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference6 articles.
1. Trends in drug development: the 1985-1986 new drug approvals.;Kaitlin;J Clin Pharmacol,1987
2. The new drug approvals of 1993, 1994, and 1995: trends in drug development.;Kaitlin;Am J Ther,1997
3. . Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkins lymphoma after responding to first-line rituximab plus chemotherapy.;Hornberger;Informa Healthcare,2012
4. . New approach to cancer therapy based on a molecularly defined cancer classification.;Cortes;Cancer J Clin,2014
5. . The prevalence and cost of unapproved uses of top-selling orphan drugs.;Kesselheim;PLoS ONE,2012
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献